Cancer of the Lung

Overview

CPG 2A - Cancer of the Lung

Abstract
AUC Description Imaging Modality GRADE / Evidence Summary of Findings Risk of Bias QOE of Recommendation ICD 10 Codes
PICO #1: In adults presenting with concerning pulmonary symptoms, such as hemoptysis, chronic cough, localized wheezing, hoarseness, or shortness of breath, should XR of the chest be performed as initial imaging for optimal patient management? Chest XR 3A Table Table Table C34,R91,D49.1
PICO #2: In adults with XR findings suggesting possible malignancy, should CT of the chest be performed to characterize the abnormality? CT Chest 2A Table Table Table C34,R91,D49.1
PICO #3: In adults with pulmonary nodules/lesions suspicious for malignancy, which imaging guided modalities can optimize lung biopsy procedures? Imaging guided biopsy 2A Table Table Table C34,R91,D49.1
PICO #4: In adults with confirmed cancer of the lung, should PET-CT imaging of the body be performed to stage the tumor compared to other imaging for optimal patient management? PET-CT 2A Table Table Table C34,R91,D49.1
PICO #5: In adults with lung cancer where there is suspected bone metastasis, should PET-CT imaging be performed compared to bone scan to detect bone involvement for optimal patient management? PET-CT 2A Table Table Table C34,R91,D49.1
PICO #6: In adults with lung cancer where there is suspected brain metastasis, should MR be performed compared to CT for optimal patient management? MR-brain 2A Table Table Table C34,R91,D49.1
PICO #7: In adults with non-small cell lung cancer (NSCLC), who have had definitive treatment, should CT imaging be performed for surveillance compared to XR for optimal patient management? CT -Surveillance 2A Table Table Table C34,R91,D49.1
PICO #8: In adults with limited stage small cell lung cancer (SCLC), who have had definitive treatment, should CT imaging be performed as part of surveillance monitoring for optimal patient management? CT -Surveillance 3B Table Table Table C34,R91,D49.1
Multidisciplinary Team with COI

Register for complimentary access

register
SEMPI
5001 American Blvd W
Suite #765
Minneapolis, MN 55437
Email: info@sempi.org
The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, allergic reactions, or adverse effects. Clinicians must at all times use their independent medical or professional judgement.
© 2019 SAGE EVIDENCE-BASED MEDICINE & PRACTICE INSTITUTE